ARCHIVES

ASCO President Swain: “Shattering Impact on Cancer Enterprise”

This article is from The Cancer Letter archive.

Vol. 39 No. 07 | February 15, 2013

Download PDF Visit The Full Archive

Related Articles

Investigators Present Latest Data On Immunologic Control of Tumors

June 1, 1975

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

SPOREs In Breast, Prostate Cancers Win $12.7 Million.

October 6, 2000

In Brief: Healy Nominated to Head NIH; Hammond, D’Angio To Step Down as Group Chairman

January 18, 1991

In Brief: NCI Providing Information On Levamisole To Patients; Macdonald Jins Temple, Salick

July 21, 1989

New Seer Report Says Five Year Relative Survival At 49 Per Cent Over all, 50 Per Cent For White

November 30, 1984